Trial site
Honor Health Research Institute
- 17running trials
- 6closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Melanoma4 trials
- Pancreatic cancer4 trials
- Colorectal cancer3 trials
- Prostate cancer3 trials
- Diffuse large B-cell lymphoma2 trials
- Myasthenia gravis2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Cytomegalovirus infection1 trial
- and 8 more
- Phase
- Phase 1/28 trials
- Phase 35 trials
- Phase 14 trials
- Phase 2/33 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Recruiting8 trials
- Completed3 trials
- Terminated3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
- IDEAYA Biosciences2 trials
- Revolution Medicines, Inc.2 trials
- AlloVir1 trial
- Arbor Research Collaborative for Health1 trial
- and 13 more
Running trials
Recruiting
Recruiting
Recruiting
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Active, not recruiting
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Lung cancer2 recruiting
- Melanoma2 recruiting
- Pancreatic cancer2 recruiting
- Prostate cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Terminated
Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors
Completed
Terminated
Terminated
Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026